These compounds may interact with:
5-hydroxytryptamine receptor 6
Potentially involved in: carcinoma; schizophrenia; alzheimer's disease; amnestic disorder; dementia; mood disorder; memory disorders; psychoses, substance-induced; amphetamine-related disorders; mood disorders; major depressive disorder; type 2 diabetes mellitus treatment adjunct; migraine; depressive disorder; postencephalitic parkinsonism; treatment-resistant schizophrenia; vascular headache; cluster headache prevention; acromegaly; parkinson's disease
Disease data sourced from Pharos.